Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest
Clinical trials sponsored by Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest, explained in plain language.
-
New hope for bile duct cancer: targeted pill may prevent recurrence after standard treatment
Disease control Recruiting nowThis study tests whether a daily pill called ivosidenib can help prevent bile duct cancer from returning in people who have already had surgery and chemotherapy. The drug targets a specific genetic change (IDH1 mutation) found in some bile duct cancers. About 40 adults with this …
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
Massive sarcoma study aims to unlock secrets of rare cancers
Knowledge-focused Recruiting nowThis study is a large registry that collects information from up to 9,000 people in Germany with sarcoma (a rare type of cancer). Researchers will track what treatments patients receive and how they do over time. The goal is to better understand the disease and improve future car…
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:02 UTC